Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000407383

Medchemexpress LLC Nafamostat mesylate | 82956-11-4 | >99.8% | 1 ML
SDP

Catalog No. 5000407383
Encompass_Preferred

Nafamostat mesylate (FUT-175) is an anticoagulant and a synthetic serine protease inhibitor. It demonstrates anticancer and antivirus effects. It induces apoptosis by up-regulating the expression of tumor necrosis factor receptor-1 (TNFR1) and can be utilized in the development of treatments for the pathological thickening of the arterial wall.

  • Anticoagulant
  • Synthetic serine protease inhibitor
  • Demonstrates anticancer effects
  • Demonstrates antivirus effects
  • Induces apoptosis by up-regulating the expression of tumor necrosis factor receptor-1 (TNFR1)
  • Can be utilized in the development of treatments for pathological thickening of the arterial wall

Catalog No. 50-004-07383 Supplier Medchemexpress LLC Supplier No. HYB0190A10MM/1ML
May include imposed supplier surcharges.
Add to Cart
Add to Cart

Nafamostat mesylate (FUT-175) is an anticoagulant and a synthetic serine protease inhibitor. It demonstrates anticancer and antivirus effects. It induces apoptosis by up-regulating the expression of tumor necrosis factor receptor-1 (TNFR1) and can be utilized in the development of treatments for the pathological thickening of the arterial wall.

  • Anticoagulant
  • Synthetic serine protease inhibitor
  • Demonstrates anticancer effects
  • Demonstrates antivirus effects
  • Induces apoptosis by up-regulating the expression of tumor necrosis factor receptor-1 (TNFR1)
  • Can be utilized in the development of treatments for pathological thickening of the arterial wall

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.